132 related articles for article (PubMed ID: 25412893)
1. Hydroxybutyl Chitosan Polymer-Mediated CD133 Antibody Coating of Metallic Stents to Reduce Restenosis in a Porcine Model of Atherosclerosis.
Li J; Zhang Q; Li D; An Y; Kutryk MB
J Cardiovasc Pharmacol Ther; 2015 May; 20(3):322-9. PubMed ID: 25412893
[TBL] [Abstract][Full Text] [Related]
2. First in vitro and in vivo results of an anti-human CD133-antibody coated coronary stent in the porcine model.
Sedaghat A; Sinning JM; Paul K; Kirfel G; Nickenig G; Werner N
Clin Res Cardiol; 2013 Jun; 102(6):413-25. PubMed ID: 23397592
[TBL] [Abstract][Full Text] [Related]
3. Anti-CD133 antibody immobilized on the surface of stents enhances endothelialization.
Li J; Li D; Gong F; Jiang S; Yu H; An Y
Biomed Res Int; 2014; 2014():902782. PubMed ID: 24734251
[TBL] [Abstract][Full Text] [Related]
4. Functionalized CD133 antibody coated stent surface simultaneously promotes EPCs adhesion and inhibits smooth muscle cell proliferation-A novel approach to prevent in-stent restenosis.
Wawrzyńska M; Duda M; Wysokińska E; Strządała L; Biały D; Ulatowska-Jarża A; Kałas W; Kraszewski S; Pasławski R; Biernat P; Pasławska U; Zielonka A; Podbielska H; Kopaczyńska M
Colloids Surf B Biointerfaces; 2019 Feb; 174():587-597. PubMed ID: 30504039
[TBL] [Abstract][Full Text] [Related]
5. Hematopoietic stem cell capture and directional differentiation into vascular endothelial cells for metal stent-coated chitosan/hyaluronic acid loading CD133 antibody.
Zhang S; Zhang F; Feng B; Fan Q; Yang F; Shang D; Sui J; Zhao H
Tissue Eng Part A; 2015 Mar; 21(5-6):1173-83. PubMed ID: 25404533
[TBL] [Abstract][Full Text] [Related]
6. Distinctive effects of CD34- and CD133-specific antibody-coated stents on re-endothelialization and in-stent restenosis at the early phase of vascular injury.
Wu X; Yin T; Tian J; Tang C; Huang J; Zhao Y; Zhang X; Deng X; Fan Y; Yu D; Wang G
Regen Biomater; 2015 Jun; 2(2):87-96. PubMed ID: 26813006
[TBL] [Abstract][Full Text] [Related]
7. Late endothelial progenitor cell-capture stents with CD146 antibody and nanostructure reduce in-stent restenosis and thrombosis.
Park KS; Kang SN; Kim DH; Kim HB; Im KS; Park W; Hong YJ; Han DK; Joung YK
Acta Biomater; 2020 Jul; 111():91-101. PubMed ID: 32434081
[TBL] [Abstract][Full Text] [Related]
8. A novel drug-eluting stent coated with an integrin-binding cyclic Arg-Gly-Asp peptide inhibits neointimal hyperplasia by recruiting endothelial progenitor cells.
Blindt R; Vogt F; Astafieva I; Fach C; Hristov M; Krott N; Seitz B; Kapurniotu A; Kwok C; Dewor M; Bosserhoff AK; Bernhagen J; Hanrath P; Hoffmann R; Weber C
J Am Coll Cardiol; 2006 May; 47(9):1786-95. PubMed ID: 16682302
[TBL] [Abstract][Full Text] [Related]
9. Vascular endothelial growth factor-bound stents: application of in situ capture technology of circulating endothelial progenitor cells in porcine coronary model.
Takabatake S; Hayashi K; Nakanishi C; Hao H; Sakata K; Kawashiri MA; Matsuda T; Yamagishi M
J Interv Cardiol; 2014 Feb; 27(1):63-72. PubMed ID: 24383571
[TBL] [Abstract][Full Text] [Related]
10. Stent coated with antibody against vascular endothelial-cadherin captures endothelial progenitor cells, accelerates re-endothelialization, and reduces neointimal formation.
Lim WH; Seo WW; Choe W; Kang CK; Park J; Cho HJ; Kyeong S; Hur J; Yang HM; Cho HJ; Lee YS; Kim HS
Arterioscler Thromb Vasc Biol; 2011 Dec; 31(12):2798-805. PubMed ID: 22015656
[TBL] [Abstract][Full Text] [Related]
11. Study of a novel coating strategy for coronary stents: evaluation of stainless metallic steel coated with VEGF and anti-CD34 antibody in vitro.
Song CL; Li Q; Zhang JC; Wang JP; Xue X; Wang G; Shi YF; Diao HY; Liu B
Eur Rev Med Pharmacol Sci; 2016; 20(2):311-6. PubMed ID: 26875902
[TBL] [Abstract][Full Text] [Related]
12. The Genous™ endothelial progenitor cell capture stent accelerates stent re-endothelialization but does not affect intimal hyperplasia in porcine coronary arteries.
van Beusekom HM; Ertaş G; Sorop O; Serruys PW; van der Giessen WJ
Catheter Cardiovasc Interv; 2012 Feb; 79(2):231-42. PubMed ID: 21834062
[TBL] [Abstract][Full Text] [Related]
13. Co-immobilization of CD133 antibodies, vascular endothelial growth factors, and REDV peptide promotes capture, proliferation, and differentiation of endothelial progenitor cells.
Duan Y; Yu S; Xu P; Wang X; Feng X; Mao Z; Gao C
Acta Biomater; 2019 Sep; 96():137-148. PubMed ID: 31284097
[TBL] [Abstract][Full Text] [Related]
14. Synthetic ePTFE grafts coated with an anti-CD133 antibody-functionalized heparin/collagen multilayer with rapid in vivo endothelialization properties.
Lu S; Zhang P; Sun X; Gong F; Yang S; Shen L; Huang Z; Wang C
ACS Appl Mater Interfaces; 2013 Aug; 5(15):7360-9. PubMed ID: 23859593
[TBL] [Abstract][Full Text] [Related]
15. CD133 antibody conjugation to decellularized human heart valves intended for circulating cell capture.
Vossler JD; Min Ju Y; Williams JK; Goldstein S; Hamlin J; Lee SJ; Yoo JJ; Atala A
Biomed Mater; 2015 Sep; 10(5):055001. PubMed ID: 26333364
[TBL] [Abstract][Full Text] [Related]
16. The impact of vascular endothelial growth factor-transfected human endothelial cells on endothelialization and restenosis of stainless steel stents.
Tang C; Wang G; Wu X; Li Z; Shen Y; Lee JC; Yu Q
J Vasc Surg; 2011 Feb; 53(2):461-71. PubMed ID: 21129910
[TBL] [Abstract][Full Text] [Related]
17. In situ endothelialization of intravascular stents coated with an anti-CD34 antibody functionalized heparin-collagen multilayer.
Lin Q; Ding X; Qiu F; Song X; Fu G; Ji J
Biomaterials; 2010 May; 31(14):4017-25. PubMed ID: 20149438
[TBL] [Abstract][Full Text] [Related]
18. Prevention of in-stent restenosis with endothelial progenitor cell (EPC) capture stent placement combined with regional EPC transplantation: An atherosclerotic rabbit model.
Huang YH; Xu Q; Shen T; Li JK; Sheng JY; Shi HJ
Cardiol J; 2019; 26(3):283-291. PubMed ID: 29611172
[TBL] [Abstract][Full Text] [Related]
19. Particle debris from a nanoporous stent coating obscures potential antiproliferative effects of tacrolimus-eluting stents in a porcine model of restenosis.
Kollum M; Farb A; Schreiber R; Terfera K; Arab A; Geist A; Haberstroh J; Wnendt S; Virmani R; Hehrlein C
Catheter Cardiovasc Interv; 2005 Jan; 64(1):85-90. PubMed ID: 15619311
[TBL] [Abstract][Full Text] [Related]
20. Effect of anti-ApoA-I antibody-coating of stents on neointima formation in a rabbit balloon-injury model.
Strang AC; Knetsch ML; Koole LH; de Winter RJ; van der Wal AC; de Vries CJ; Tak PP; Bisoendial RJ; Stroes ES; Rotmans JI
PLoS One; 2015; 10(3):e0122836. PubMed ID: 25821966
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
